The preferential cytolytic T lymphocyte response to immunodominant minor histocompatibility antigen peptides

Transplantation

Volumn 62, Issue 2, 1996, Pages 283-291

  Nevala, Wendy K ^a   Wettstein, Peter J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; IMMUNOMODULATION; MINOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION;

ANIMALS; H-2 ANTIGENS; IMMUNIZATION; IMMUNODOMINANT EPITOPES; MICE; MICE, INBRED STRAINS; MINOR HISTOCOMPATIBILITY ANTIGENS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029939660     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199607270-00022     Document Type: Article

References (33)

1. Snell GD, Stimpfling JH. Genetics of tissue transplantation. In: Green EL (ed.) Biology of the laboratory mouse (2nd ed). New York: McGraw-Hill, 1966: 457.
2. Bailey DW. Genetics of histocompatibility in mice. I. new loci and congenic lines. Immunogenetics 1975; 2: 249.
3. Rotzschke O, Falk K, Deres K, et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 1990; 348: 252.
4. Wallny H, Rammensee H. Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature 1990; 343: 275.
5. deBueger M, Verreck F, Blokland E, et al. Isolation of an HLA-A2.1 extracted human minor histocompatibility peptide. Eur J Immunol 1993; 23: 614.
6. den Haan JM, Sherman NE, Blokland E, et al. Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995; 268: 1476.
7. Loveland B, Wang C, Yonekawa H, Hermel E, Lindahl K. Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein. Cell 1990; 60: 971.
8. Wang CR, Loveland BE, Lindahl KF. H2 M3 encodes the MHC class I molecule presenting the maternally transmitted antigen of the mouse. Cell 1991; 66: 335.
9. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee H. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991; 351: 290.
10. Wettstein PJ, van Bleek GM, Nathenson SG. Differential binding of a minor histocompatibility antigen peptide to H2 class I molecules correlates with immune responsiveness. J. Immunol 1993; 150: 2753.
11. Wettstein PJ, Bailey DW. Immunodominance in the immune response to "multiple" histocompatibility antigens. Immunogenetics 1982; 16: 47.
12. Wettstein P. Immunodominance in the T-cell response to multiple non-H2 histocompatibility antigens. II. Observation of a hierarchy among dominant antigens. Immunogenetics 1986; 24: 24.
13. Yin L, Poirier G, Neth O, Hsuan JJ, Stauss HJ. Few peptides dominate cytotoxic T lymphocyte response to single and multiple minor histocompatibility antigens. Int Immunology 1993; 5: 1003.
14. Franksson L, Petersson M, Kiessling R, Karre K. Immunization against tumor and minor histocompatibility antigens by eluted cellular peptides loaded on antigen processing defective cells. Eur J Immunol 1993; 23: 2606.
15. Wolpert E, Franksson L, Karre K. Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides. Int Immunol 1995; 7: 919.
16. Bailey DW. Recombinant inbred strains. Transplantation 1971; 11: 325.
17. Ljunggren HG, Karre K. Host resistance directed selectively against H2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 1985; 162: 1745.
18. VonBoehmer H, Hengartner H, Nabholz M, Lernhardt W, Schreier MH, Haas W. Fine specificity of a continuously growing killer cell clone specific for HY antigen. Eur J Immunol 1979; 9: 592.
19. +. Proc Natl Acad Sci USA 1979; 76: 3455.
20. Jones B, Janeway CA, Jr. Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature 1981; 292: 547.
21. van Els C, D'Amaro J, Pool J, Blokland E. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 1992; 35: 161.
22. Tremblay N, Fontaine P, Perreault C. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes. Transplantation 1994; 58: 59.
23. Korngold R, Wettstein P J. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens. J Immunol 1990; 145: 4079.
24. Strausbauch MA, Madden BJ, Wettstein PJ, Landers JP. Sensitivity enhancement and second-dimensional information from solid phase extraction-capillary electrophoresis (SPECE) of entire high-performance liquid chromatography fractions. Electrophoresis 1995; 16: 541.
25. bm mutants. J Virol 1990; 64: 1192.
26. Roopenian DC, Christianson GJ, Davis AP, Zuberi AR, Mobraaten LE. The genetic origin of minor histocompatibility antigens. Immunogenetics 1993; 38: 131.
27. Atchley WR, Fitch W. Genetic affinities of inbred mouse strains of uncertain origin. Mol Biol Evol 1993; 10: 1150.
28. Gavin MA, Gilbert MJ, Riddell SR, Greenberg PD, Bevan MJ. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol 1993; 151: 3971.
29. de Maeyer E, de Maeyer-Guignard J, Bailey DW. Effect of mouse genotype on interferon production. I. Lines congenic at the If-1 locus. Immunogenetics 1975; 1: 438.
30. Huczko EL, Bodnar WM, Benjamin D, et al. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol 1993; 151: 2572.
31. Matzinger P, Bevan MJ. Induction of H2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. Cell Immunol 1977; 33: 92.
32. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994; 264: 961.
33. Arnold D, Faath S, Rammensee HG, Schild H. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 1995; 182: 885.